April 23, 2024 Media Coverage from ARCH Venture Partners | Share With ARCH funding, Xaira Therapeutics aims to reinvent drug R&D by using artificial intelligence to deliver transformative medicines
April 18, 2024 Media Coverage from ARCH Venture Partners | Share ARCH-backed startup Metsera launches to develop drugs for obesity
April 9, 2024 Media Coverage from ARCH Venture Partners | Share ARCH funds neuropsychiatry company Seaport Therapeutics, led by the team behind Karuna Therapeutics
February 27, 2024 Media Coverage from ARCH Venture Partners | Share Managing Director Kristina Burow named to STAT’s 2024 STATUS list alongside other top leaders shaping the industry
November 1, 2023 Media Coverage from ARCH Venture Partners | Share With ARCH funding, Gate Biosciences finds new way to attack diseases
September 21, 2023 Media Coverage from ARCH Venture Partners | Share Four ARCH-backed companies named to Endpoints 11 list of most exciting biotech startups in 2023
July 14, 2023 Press Releases from ARCH Venture Partners | Share ARCH Venture Partners Announces Appointment of Kent Rogers as Venture Partner
May 25, 2023 Press Releases from ARCH Venture Partners | Share ARCH Venture Partners Announces Appointment of Kevin Hrusovsky as Venture Partner
May 23, 2023 Press Releases from ARCH Venture Partners | Share ARCH Venture Partners Announces Appointment of Jami Rubin as Venture Partner
April 25, 2023 Media Coverage from ARCH Venture Partners | Share ARCH leads Series A for Orbital, supporting research to unleash full potential of RNA medicines
April 6, 2023 Press Releases from ARCH Venture Partners | Share ARCH Venture Partners Announces Appointment of Brian Cuneo as Senior Partner
March 7, 2023 Media Coverage from ARCH Venture Partners | Share ARCH leads Volastra $60 million financing round
